arrow
E

Enrico Melis

Institut Curie
H指数:13
被引数:492

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

How Should Primary Pulmonary Sarcoma be Staged? Results of an International Multicentre Analysis

如何对原发性肺肉瘤进行分期?一项国际多中心分析的结果

2026-02-010
PRE
Outcome of patients with curative-intent treatment for primary pulmonary sarcoma: Results from an international multicenter retrospective study

原发性肺肉瘤根治性治疗患者的结局:一项国际多中心回顾性研究的结果

2025-12-011
OAAI
TP53 co-mutations increase risk of recurrence in EGFR-mutated stage I lung adenocarcinoma

TP53共突变增加了EGFR突变的Ⅰ期肺腺癌的复发风险。

2025-07-100
PRE
Predictive and prognostic factors in patients with anaplastic lymphoma kinase rearranged early-stage lung adenocarcinoma

间变性淋巴瘤激酶重排早期肺腺癌患者的预测和预后因素

2024-11-120
PRE
Melanoma in Adolescents and Young Adults (AYAs): An Italian Multi-Centric Retrospective Experience

青少年和年轻人的黑色素瘤 (AYAs): 意大利的多中心回顾性经验

2024-10-281
OAAI
Surgical and survival outcomes with perioperative or neoadjuvant immune-checkpoint inhibitors combined with platinum-based chemotherapy in resectable NSCLC: A systematic review and meta-analysis of randomised clinical trials
2023-12-0121
OAAI
Analysis of predictive factors of unforeseen nodal metastases in resected clinical stage I NSCLC

临床 ⅰ 期非小细胞肺癌手术切除后发生不可预见淋巴结转移的预测因素分析

2023-11-075
OAAI